title: Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli.
abstract: The antibacterial activity and acting mechanism of silver nanoparticles (SNPs) on Escherichia coli ATCC 8739 were investigated in this study by analyzing the growth, permeability, and morphology of the bacterial cells following treatment with SNPs. The experimental results indicated 10 microg/ml SNPs could completely inhibit the growth of 10(7) cfu/ml E. coli cells in liquid Mueller-Hinton medium. Meanwhile, SNPs resulted in the leakage of reducing sugars and proteins and induced the respiratory chain dehydrogenases into inactive state, suggesting that SNPs were able to destroy the permeability of the bacterial membranes. When the cells of E. coli were exposed to 50 microg/ml SNPs, many pits and gaps were observed in bacterial cells by transmission electron microscopy and scanning electron microscopy, and the cell membrane was fragmentary, indicating the bacterial cells were damaged severely. After being exposed to 10 microg/ml SNPs, the membrane vesicles were dissolved and dispersed, and their membrane components became disorganized and scattered from their original ordered and close arrangement based on TEM observation. In conclusion, the combined results suggested that SNPs may damage the structure of bacterial cell membrane and depress the activity of some membranous enzymes, which cause E. coli bacteria to die eventually.
authors: Guangdong Institute of Microbiology, Guangzhou, China.
authors: Wen-Ru
authors: WR
authors: Li
authors: Xiao-Bao
authors: XB
authors: Xie
authors: Qing-Shan
authors: QS
authors: Shi
authors: Hai-Yan
authors: HY
authors: Zeng
authors: You-Sheng
authors: YS
authors: Ou-Yang
authors: Yi-Ben
authors: YB
authors: Chen
mesh_terms: D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000494:pharmacology*; D002241:Carbohydrates; D002462:Cell Membrane / Q000187:drug effects; D022162:Cytoplasmic Vesicles / Q000187:drug effects; D004579:Electron Transport / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects* / Q000201:enzymology / Q000254:growth & development / Q000648:ultrastructure; D029968:Escherichia coli Proteins / Q000378:metabolism; D053768:Metal Nanoparticles / Q000737:chemistry; D008826:Microbial Sensitivity Tests; D010084:Oxidation-Reduction; D010088:Oxidoreductases / Q000378:metabolism; D012834:Silver / Q000737:chemistry / Q000494:pharmacology*
chemical_list: D000900:Anti-Bacterial Agents; D002241:Carbohydrates; D029968:Escherichia coli Proteins; D012834:Silver; D010088:Oxidoreductases